A Randomised, Placebo-controlled, Double-blind, Cross-over Study in Healthy Men and Women to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Intra-anal Doses of NRL001 for Three Doses Using a Cream Formulation Relative to a Matched Placebo Formulation for Reference

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
This study is conducted to explore the safety and tolerability and plasma pharmacokinetics of NRL001 after single intra-anal dose of 1mL cream at increasing concentrations.
Epistemonikos ID: af0ea97ca10be5ed84e51801ec46bc9140dda160
First added on: May 06, 2024